IFNA17 and cancer: More importantly, other than cancer signaling pathways, immune processes such as IL-2 and IL-6 signaling pathways, INF-α and INF-γ response, and complement activity were dominantly associated with TBX22low status (14 terms were significant GSEA results, 13 were immune- or cancer-related processes).